Healthcare


 Amcor Powers Up for Healthcare Boom: Expands Thermoforming Capacity in North America

Amcor Powers Up for Healthcare Boom: Expands Thermoforming Capacity...

February 01, 2024 07:32 PM AEDT | By Team Kalkine Media

Amcor, a global leader in packaging solutions, has recently revealed plans to expand its thermoforming production capacity in North America. This stra...

 Cramer reacts to Eli Lilly’s telehealth service for weight-loss drug

Cramer reacts to Eli Lilly’s telehealth service for weight-loss drug

January 05, 2024 09:29 AM AEDT | By Invezz

Eli Lilly & Co (NYSE: LLY) was the talk of the market on Thursday after the pharmaceutical giant launched LillyDirect – a website that will enable...

 After a bruising 2023, Bristol-Myers Squibb (BMY) forges a risky M&A strategy

After a bruising 2023, Bristol-Myers Squibb (BMY) forges a risky M&A...

December 27, 2023 03:02 PM AEDT | By Invezz

Bristol-Myers Squibb (NYSE: BMY), the giant pharmaceutical company, had a difficult year as its stock tanked. Its shares crashed by over 28% in 2023,...

 AbbVie bolsters portfolio with $10.1 billion ImmunoGen buyout for cancer therapy

AbbVie bolsters portfolio with $10.1 billion ImmunoGen buyout for ca...

December 02, 2023 12:50 AM AEDT | By Invezz

AbbVie has announced its acquisition of ImmunoGen for $10.1 billion in cash, marking a strategic move amidst rising competition for their leading trea...

 Days after US and UK approval, Eli Lilly’s Tirzepatide approved in the EU

Days after US and UK approval, Eli Lilly’s Tirzepatide approved in t...

November 11, 2023 05:05 AM AEDT | By Invezz

Eli Lilly (LLY) stock price movement has experienced a whirlwind since Wednesday’s approval of its diabetes medication, tirzepatide, for chronic...

 Find out why these biotechnology firms surpassed market gains

Find out why these biotechnology firms surpassed market gains

October 20, 2023 09:06 PM AEDT | By Akanksha Vashisht

Summary,The Nasdaq composite index fell by 1% on Thursday.,Cidara Therapeutics Inc. reported a revenue of US$7.6 million for Q2 2023.,INmune Bio Inc....

 These Nasdaq-listed healthcare stocks beat Monday’s market gains

These Nasdaq-listed healthcare stocks beat Monday’s market gains

October 03, 2023 09:38 PM AEDT | By Akanksha Vashisht

Summary,The Nasdaq Composite Index rose by 0.67% on Monday, while the Nasdaq Healthcare Index fell by 0.67%.,Spok Holdings Inc., a healthcare communic...

 Blue Shield of California to trim its partnership with CVS Health

Blue Shield of California to trim its partnership with CVS Health

August 18, 2023 03:16 AM AEST | By Invezz

Blue Shield of California plans on trimming its partnership with CVS Health Corp (NYSE: CVS) to cut costs. Shares of the healthcare company are down 8...

 UNH wins provisional clearance from U.K. CMA to acquire EMIS

UNH wins provisional clearance from U.K. CMA to acquire EMIS

August 12, 2023 03:03 AM AEST | By Invezz

UnitedHealth Group Inc (NYSE: UNH) is in the green this morning after the British regulator provisionally cleared its £1.2 billion acquisition of...

 Eli Lilly stock is a ‘buy’ after its blockbuster Q2

Eli Lilly stock is a ‘buy’ after its blockbuster Q2

August 10, 2023 02:44 AM AEST | By Invezz

Eli Lilly & Co (NYSE: LLY) has already gained 45% year-to-date but a Jefferies analyst is convinced that the stock is not out of juice just yet. E...

 Novo Nordisk shares jump another 17% on the back of obesity drug

Novo Nordisk shares jump another 17% on the back of obesity drug

August 09, 2023 01:20 AM AEST | By Invezz

Shares of Novo Nordisk A/S (NYSE: NVO) are up 17% this morning after the pharmaceutical behemoth reported results of its “SELECT” trial. W...

 Hims & Hers stock price has gone parabolic: Is it a good buy?

Hims & Hers stock price has gone parabolic: Is it a good buy?

August 08, 2023 10:30 PM AEST | By Invezz

Hims & Hers (NYSE: HIMS) stock price bounced back after the company published strong results and boosted its forward guidance. The shares closed t...

 As Cassava Sciences (SAVA) stock slips, is it safe to buy the dip?

As Cassava Sciences (SAVA) stock slips, is it safe to buy the dip?

August 08, 2023 03:14 AM AEST | By Invezz

Cassava Sciences (NASDAQ: SAVA) stock price sell-off intensified as the recent momentum faded. SAVA shares plunged to a low of $18.30 on Monday, the l...

 Haleon share price analysis: where technicals meet fundamentals

Haleon share price analysis: where technicals meet fundamentals

August 02, 2023 08:17 PM AEST | By Invezz

Haleon (LON: HLN) share price retreated even after the company published strong financial results and boosted its forward guidance. The stock plunged...

 Top-performing Healthcare Stocks in July 2023

Top-performing Healthcare Stocks in July 2023

July 24, 2023 11:50 PM AEST | By Team Kalkine Media

Top-performing Healthcare Stocks in July 2023

 Johnson & Johnson files lawsuit against Biden administration

Johnson & Johnson files lawsuit against Biden administration

July 19, 2023 06:07 AM AEST | By Invezz

Johnson & Johnson (NYSE: JNJ) is in focus today after the pharmaceutical behemoth filed a lawsuit against the Biden Administration in a federal di...

 Eli Lilly is buying Dice Therapeutics for $2.4 billion

Eli Lilly is buying Dice Therapeutics for $2.4 billion

June 21, 2023 12:15 AM AEST | By Invezz

Dice Therapeutics Inc (NASDAQ: DICE) opened more than 35% up this morning after Eli Lilly & Co (NYSE: LLY) said it will buy the immunology company...

 Francis deSouza just resigned as the CEO of Illumina Inc

Francis deSouza just resigned as the CEO of Illumina Inc

June 12, 2023 04:14 AM AEST | By Invezz

Illumina Inc (NASDAQ: ILMN), on Sunday, said its board has accepted resignation from CEO Francis deSouza who’s been leading the gene sequencing...

 Biogen inches closer to FDA approval for its Alzheimer’s drug

Biogen inches closer to FDA approval for its Alzheimer’s drug

June 11, 2023 04:33 AM AEST | By Invezz

Shares of Biogen Inc (NASDAQ: BIIB) gained nearly 10% in extended hours after the biotech firm edged closer to winning FDA approval for its Alzheimer&...

 Merck just sued the Biden administration: find out why

Merck just sued the Biden administration: find out why

June 07, 2023 01:12 AM AEST | By Invezz

Merck & Co Inc (NYSE: MRK) is in focus this morning after the pharmaceutical giant sued the Biden administration in a federal district court. Here...

Recent Articles

 Pepe, Bonk, Dogecoin prices surge as Bitcoin Dogs ICO raises $5.1M
February 28, 2024 11:02 AM AEDT | By Invezz

 Arweave and Injective prices rise as Pullix token sale thrives
February 28, 2024 11:02 AM AEDT | By Invezz

 It’s time to move to the sidelines in Arm stock – analyst says
February 28, 2024 09:04 AM AEDT | By Invezz

 Splunk Q4 earnings report: revenue jumped 19% YoY
February 28, 2024 08:20 AM AEDT | By Invezz

 Uniswap introduces wallet extension, other tools for smarter swaps
February 28, 2024 05:52 AM AEDT | By Invezz


Top Listed Companies